戻る Agenda
[S03 ]Collaboration with WHO for Global Health
Session Chair(s)
Junko Sato, PhD
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
When facing an outbreak of socially-impactful infectious diseases such as the Ebola virus, WHO may work with pertinent regulatory agencies not only for disease containment but also on clinical studies of possible therapeutics. But other WHO activities, such as pre-qualification or reliance pathway, are of high interest in developed countries. Many observers still have the strong impression that WHO mostly works with developing countries from the global public health perspective. This session will explain what activities WHO conducts, and discuss how the industry and/or regulatory agencies can collaborate with WHO to contribute to global health.
Speaker(s)
Putting Reliance into Practice: WHO’s Activities on Regulatory Systems Strengthening [Recorded Presentation]
Samvel Azatyan, MD, PhD
World Health Organization (WHO), Switzerland
Team Lead, Regulatory Convergence and Networks (RCN/REG)
Collaboration with WHO Global Health Medicines
Agnès Saint-Raymond, DrMed
European Medicines Agency, Netherlands
Head of Division International Affairs
Collaboration with WHO for Global Health from Industry Perspectives
Shinji Hatakeyama
Eisai Co., Ltd., Japan
Director